ArticleLasers in medical science2025
3D-printed surface coated with natural photosensitizer for photodynamic inactivation of methicillin-resistant Staphylococcus aureus using visible light.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The use of polylactic acid (PLA) coated with photosensitizer (PS) and activated by visible light could represent a novel, inexpensive, and eco-friendly self-sterilizing material to produce customized biomedical devices with antimicrobial properties. The rise of antibiotic resistance highlights the urgent need for alternative antimicrobial strategies, like Methicillin-resistant Staphylococcus aureus (MRSA), which represents a major global health concern, responsible for severe invasive diseases to minor skin infections and asymptomatic nasal colonization. Antimicrobial photodynamic inactivation (aPDI) has emerged as a promising technique, using the synergistic effects of light, oxygen, and a photosensitizer to generate reactive oxygen species (ROS) that eradicate bacteria. Brazil's rich biodiversity offers a reservoir of natural compounds, such as Eugenia uniflora (EU) extract, which has demonstrated effective antimicrobial activity when used in aPDI. This study explored the development of a 3D-printed self-sterilizing surface by combining aPDI and EU extract to combat MRSA. Polylactic acid (PLA) discs were impregnated with EU extract and evaluated for their ability to reduce MRSA colonies under visible light, assessing bacterial growth at 0, 8, and 24 h. Results showed significant reductions in MRSA colonies under visible light after 8 h (~ 50%), which were enhanced at 24 h (~ 70%). ROS involvement was confirmed, with EDTA and azide restoring ~ 50% of bacterial growth, implicating metal ions and singlet oxygen in the mechanism. DNA damage assays revealed heightened genotoxic effects under light exposure, as shown by DNA smearing. This innovative approach underscores the potential of EU coated 3D-printed surfaces in reducing nosocomial infections. Further studies will examine ROS generation and antibiofilm capabilities.
Indexed as
Identifiers
39988576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.